| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FMR1 autosomal homolog 1 | 0.656 | 0.615 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2018 | ||||||||
|
SEC14 and spectrin domain containing 1 | 0.821 | 0.231 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
muskelin 1 | 0.769 | 0.269 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
activating signal cointegrator 1 complex subunit 2 | 0.633 | 0.615 | 3.1E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2018 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2015 | ||||||||
|
ATP binding cassette subfamily G member 1 | 0.560 | 0.692 | 0.11 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2016 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 3 | 0.821 | 0.346 | 2.9E-04 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
protein tyrosine phosphatase receptor type G | 0.619 | 0.731 | 5.1E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
long intergenic non-protein coding RNA 1121 | 0.751 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
retinoic acid receptor responder 2 | 0.519 | 0.731 | 2.7E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
6-pyruvoyltetrahydropterin synthase | 0.636 | 0.654 | 6.5E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
membrane palmitoylated protein 6 | 0.821 | 0.077 | 0.82 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
Ras protein specific guanine nucleotide releasing factor 2 | 0.644 | 0.615 | 0.15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ribophorin II | 0.686 | 0.462 | 0.11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
LIM domain 7 | 0.722 | 0.500 | 2.5E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
retinoid X receptor gamma | 0.674 | 0.615 | 0.42 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
multiple C2 and transmembrane domain containing 1 | 1.000 | 0.038 | 9.3E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
ribokinase | 0.890 | 0.077 | 5.2E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
nuclear factor I A | 0.599 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2013 | 2013 | ||||||||
|
nuclear transcription factor Y subunit gamma | 0.792 | 0.423 | 0.11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
COMM domain containing 10 | 0.780 | 0.269 | 6.5E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
protocadherin 12 | 0.722 | 0.346 | 2.9E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 |